Sort
16,300 grants matching “fatty liver disease”
Long-lived mice and species as test beds for drug and pathway discovery
$520,675Richard A. Miller · California Pacific Med Ctr Res Institute · U19 · FY2021 · AG
A Multi-Level Intervention to Promote Healthy Beverage Intake through Childcare
$520,582Anisha Indravadan Patel · Stanford University · R01 · FY2024 · DK
Exploring the Fetal Origins Hypothesis in Diverse Youth
$520,552Dana Dabelea · University Of Colorado Denver · R01 · FY2012 · DK
Molecular markers of early cardiometabolic health transitions in the CARDIA study
$520,492Ravi Shah · Massachusetts General Hospital · R01 · FY2020 · HL
Clinical Research on Nonalcoholic Fatty Liver Disease
$520,416Joel Edward Lavine · Columbia University Health Sciences · U01 · FY2010 · DK
Comprehensive, Cross Platform-Validated 13C Flux Measures of Intra-and Inter-tissue Metabolism
$520,376Graeme F Mason · Yale University · R01 · FY2017 · DK
Comprehensive, Cross Platform-Validated 13C Flux Measures of Intra-and Inter-tissue Metabolism
$520,376Graeme F Mason · Yale University · R01 · FY2019 · DK
Comprehensive, Cross Platform-Validated 13C Flux Measures of Intra-and Inter-tissue Metabolism
$520,376Graeme F Mason · Yale University · R01 · FY2016 · DK
Adiponectin signaling and macrophage function
$520,199Lily Q. Dong · University Of Texas Hlth Science Center · R01 · FY2025 · DK
Adiponectin signaling and macrophage function
$520,199Lily Q. Dong · University Of Texas Hlth Science Center · R01 · FY2023 · DK
Alcohol and intestinal microvascular endothelium-immune axis and the role of gut derived immune nutrients
$520,191Gail Ann Cresci · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · AA
Intestine FXR activation by LGG-derived nanoparticles in alcohol-associated liver disease
$520,062Wenke Feng · Tulane University Of Louisiana · R01 · FY2025 · AA
Intestine FXR activation by LGG-derived nanoparticles in alcohol-associated liver disease
$520,062Wenke Feng · Tulane University Of Louisiana · R01 · FY2024 · AA
The 2020 ESPINA study follow-up Exam: Fungicides, Insecticides, Inflammation and Child Development
$519,992Jose Ricardo Suarez · University Of California, San Diego · R01 · FY2021 · ES
DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis
$519,971Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2020 · DK
DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis
$519,971Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2022 · DK
DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis
$519,971Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2019 · DK
DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis
$519,971Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2021 · DK
A Glucocorticoid Receptor-SETDB2 Co-Regulated Liver Metabolic Gene Program
$519,964Timothy F Osborne · Johns Hopkins University · R01 · FY2022 · DK
Transforming Growth Factor - Beta Superfamily Signaling in Diabetes and Obesity
$519,961Sushil Rane · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK
RAGE/mDia1, Macrophage Trafficking and Inflammation in High Fat Feeding
$519,928Ann Marie Schmidt · New York University School Of Medicine · R01 · FY2019 · DK
RAGE/mDia1, Macrophage Trafficking and Inflammation in High Fat Feeding
$519,928Ann Marie Schmidt · New York University School Of Medicine · R01 · FY2020 · DK
The role of hepatocyte tPA in hepatic VLDL production.
$519,897Ze Zheng · Medical College Of Wisconsin · R01 · FY2025 · HL
The role of hepatocyte tPA in hepatic VLDL production.
$519,897Ze Zheng · Medical College Of Wisconsin · R01 · FY2023 · HL
Hepatic TGFbeta1 in Control of Type 2 Diabetes and NASH via FoxO1 Signaling
$519,896Shaodong Guo · Texas A&M Agrilife Research · R01 · FY2022 · DK